Trabectedin–olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.11.019